TRUST2 · 1042-TSC-3002
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC OLE). EudraCT: 2021-003384-10
Sponsor: Marinus
Phase: III
Area: Epilepsy